Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2013
09/12/2013WO2013131927A1 Combining dna-damaging agents and modulators of actin polymerization for the treatment of cancer
09/12/2013WO2013131923A1 Substituted azabicycles and use thereof
09/12/2013WO2013131906A1 Dialysis composition comprising citrate, calcium and magnesium
09/12/2013WO2013131901A1 Benzodioxanes in combination with other actives for inhibiting leukotriene production
09/12/2013WO2013131879A1 New application for pasireotide
09/12/2013WO2013131646A1 Dosage form comprising lopinavir and ritonavir
09/12/2013WO2013131645A1 Dosage form comprising non-crystalline lopinavir and crystalline ritonavir
09/12/2013WO2013131609A1 Triazolopyrazine derivatives
09/12/2013WO2013131465A1 Polymorphs of n-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-(5-((2-(methylsulfinyl)ethylamino)methyl)-2-furanyl)-quinazoline-4-aminexylene sulfonate and preparation method and uses thereof
09/12/2013WO2013131424A1 4-quinazoline amine derivative and application thereof
09/12/2013WO2013131409A1 Phenyl-oxazolyl derivatives, preparation method thereof, and related application of the phenyl-oxazolyl derivatives as an impdh inhibitor
09/12/2013WO2013131408A1 Substituted heterocyclic acetamides as kappa opioid receptor (kor) agonists
09/12/2013WO2013131406A1 Application of depolymerized sea cucumber glycosaminoglycans in preparing medicament for prevention and treatment of thromboembolic diseases
09/12/2013WO2013131324A1 Use of rupatadine in the manufacture of pharmaceutical composition for treating chronic obstructive pulmonary disease
09/12/2013WO2013131270A1 Scutellarin hydrate and preparation method and use thereof
09/12/2013WO2013131182A1 Guanosine-rich oligonucleotide (gro) compostions, methods and uses for treating respiratory syncytial virus infection
09/12/2013WO2013131164A1 Pharmaceutical composition containing conventional liposomes and prolonged-circulation liposomes for the treatment of visceral leishmaniasis
09/12/2013WO2013131157A1 Combination of a monosubstituted sulfamate derivative of the natural monosaccharide d-fructose (topiramate) with an anti-depressant from the phenyl ketone class (bupropion) for treating obesity and plurimetabolic syndromes
09/12/2013WO2013131143A1 Micrornas and uses thereof
09/12/2013WO2013131125A1 Dietary supplement
09/12/2013WO2013131124A1 Dietary supplement for pet mammals
09/12/2013WO2013112959A8 Antifibrotic compounds and uses thereof
09/12/2013WO2013109972A3 Therapeutic compounds
09/12/2013WO2013102936A4 N-(3-((diethylamino) methyl)-4-hydroxyphenyl)-n-(quinolin-4-yl) sulfonamides for the treatment of tuberculosis and process of preparation thereof
09/12/2013WO2013102842A3 Device and composition for drug release
09/12/2013WO2013092673A3 New combination
09/12/2013WO2013084214A3 Pyrazinoic acid prodrugs activated by esterases of mycobacteria
09/12/2013WO2013058838A3 Conveniently injectable or implantable sustained-release antioxidant formulations for therapies of ocular maladies or cancer
09/12/2013WO2013043232A8 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer
09/12/2013WO2013040552A8 Methods of promoting immune tolerance
09/12/2013WO2013032960A3 Vitamin d receptor - coregulator inhibitors
09/12/2013WO2012103524A8 Inhibitors of mtor kinasa as anti- viral agents
09/12/2013WO2012100366A8 Liposome and personal care composition comprising thereof
09/12/2013WO2012096873A9 Methods and drug products for treating alzheimer's disease
09/12/2013WO2012021629A3 Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
09/12/2013WO2007024945A8 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
09/12/2013US20130239239 Lmcd1 cancer markers and methods for their use
09/12/2013US20130239234 Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain
09/12/2013US20130237721 Therapeutic compounds and methods of use
09/12/2013US20130237696 Vascular therapeutics
09/12/2013US20130237632 Shape memory polymer medical device
09/12/2013US20130237611 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
09/12/2013US20130237610 Dynamic balancing of autonomic nervous system through vitamin mk-7
09/12/2013US20130237609 Cellulose derivatives for enhancing bioavailability of flavonoids
09/12/2013US20130237608 Prolonged Release Pharmaceutical Composition Containing 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)Phenol
09/12/2013US20130237607 Treatment of connective tissue diseases of the skin
09/12/2013US20130237605 Compositions, methods, and kits for regulating energy metabolism
09/12/2013US20130237604 Compositions and methods for the treatment of inflammatory conditions
09/12/2013US20130237603 Acetylcysteine Compositions and Methods of use Thereof
09/12/2013US20130237602 Valproic acid drug delivery systems and intraocular therapeutic uses thereof
09/12/2013US20130237600 Treating eczema and/or psoriasis
09/12/2013US20130237598 Antiviral compositions
09/12/2013US20130237597 Extended-release solid oral dosage form for homeopathic compositions
09/12/2013US20130237596 Uses of 15-benzylidene-14-deoxy-11,12-didehydroandrographolide Derivatives in the Preparation of Antineoplastic Drugs
09/12/2013US20130237593 Multi-site administration
09/12/2013US20130237592 Method for producing a protein of interest at the site of a clot
09/12/2013US20130237591 Pharmaceutical composition for treating adverse reactions due to administration of spiegelmers
09/12/2013US20130237590 Assessing thyroid neoplasms
09/12/2013US20130237588 Vascular therapeutics
09/12/2013US20130237587 Mir 204, mir 211, their anti-mirs, and therapeutic uses of same
09/12/2013US20130237586 DELIVERY OF dsRNA TO ARTHROPODS
09/12/2013US20130237584 CANCER THERAPY USING Bcl-XL-SPECIFIC siNA
09/12/2013US20130237582 Pharmaceutical combination of paclitaxel and a cdk inhibitor
09/12/2013US20130237581 3-phenoxymethylpyrrolidine compounds
09/12/2013US20130237580 Peptidomimetic compounds as immunomodulators
09/12/2013US20130237579 Stable pharmaceutical compositions comprising one or more hmg-coa reductas inhibitiors
09/12/2013US20130237577 Compositions comprising amino acids for prevention and/or treatment of renal disorders
09/12/2013US20130237576 Dexmedetomidine Premix Formulation
09/12/2013US20130237574 Tablet formulations comprising valsartan
09/12/2013US20130237573 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS
09/12/2013US20130237572 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
09/12/2013US20130237570 Formulation and Use and Manufacture Thereof
09/12/2013US20130237569 Modulators of atp-binding cassette transporters
09/12/2013US20130237568 Modulators of atp-binding cassette transporters
09/12/2013US20130237567 Iminosugars and methods of treating viral diseases
09/12/2013US20130237564 Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
09/12/2013US20130237562 PI3 KINASE/mTOR DUAL INHIBITOR
09/12/2013US20130237561 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
09/12/2013US20130237560 Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
09/12/2013US20130237559 Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid
09/12/2013US20130237558 Stability of Hydromorphone Hydrochloride Solutions
09/12/2013US20130237557 Treatment
09/12/2013US20130237556 Berberine alkaloid as a medicament for prevention and treatment of neural disease
09/12/2013US20130237554 Combination
09/12/2013US20130237551 Substituted 5-fluoro-1H-pyrazolopyridines and their use
09/12/2013US20130237550 Arylvinylazacycloalkane compounds for constipation
09/12/2013US20130237549 Pharmaceutical combination
09/12/2013US20130237546 Use of melanoma inhibitory activity (mia) protein as an early indicator for therapeutic response in melanoma
09/12/2013US20130237543 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
09/12/2013US20130237540 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
09/12/2013US20130237539 Compounds and Compositions for Treating Cancer
09/12/2013US20130237535 Fatty acid synthase inhibitors
09/12/2013US20130237532 Indole and indazole compounds as an inhibitor of cellular necrosis
09/12/2013US20130237531 Compounds and methods for kinase modulation, and indications therefor
09/12/2013US20130237527 Combinations of medicaments, containing pde4-inhibitors and ep4-receptor-antagonists
09/12/2013US20130237526 Pharmaceutical composition
09/12/2013US20130237519 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
09/12/2013US20130237518 Novel compounds that are erk inhibitors
09/12/2013US20130237512 Stabilizing compositions for antibiotics and methods of use
09/12/2013US20130237511 Copper Ion Delivery Platform for Pharmaceutical Agents
1 ... 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 ... 7860